Medical News

RSS

Resverlogix completes Phase 2 ASSERT trial enrollment 5 months ahead of schedule

Resverlogix Corp. announced today the completion of patient enrollment in the Phase 2 clinical study of its lead drug RVX-208. "The completion of enrollment for our Phase 2 ASSERT trial, a full 5 months ahead of our original schedule, is a very exciting achievement for our staff and our collaborators at the Cleveland Clinic.

9 Feb 2010

High BP may predict dementia in older adults with cognitive impairment

High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.

9 Feb 2010

Texting-on-the-go can cause fatal accidents

Siobhan Wicks was texting her roommate while walking down the stairs in her Aurora home when suddenly her world turned topsy turvy.

9 Feb 2010

U.S. Court dismisses two of ADI's patent infringement claims against Knowles Electronics

The U.S. District Court in the District of Delaware has ordered the dismissal of two patent infringement claims originally filed by Analog Devices, Inc. (ADI) against Knowles Electronics. The order was issued pursuant to the withdrawal of its claims by Analog Devices under a stipulation of dismissal signed by both parties.

9 Feb 2010

Exposure to electronic media is not linked to headaches

Use of most electronic media is not associated with headaches, at least not in adolescents. A study of 1025 13-17 year olds, published in the open access journal BMC Neurology, found no association between the use of computer games, mobile phones or television and the occurrence of headaches or migraines.

9 Feb 2010

Health hazards: Clinging tobacco smoke reacts with nitrous acid and produces dangerous carcinogens

Nicotine in third-hand smoke, the residue from tobacco smoke that clings to virtually all surfaces long after a cigarette has been extinguished, reacts with the common indoor air pollutant nitrous acid to produce dangerous carcinogens. This new potential health hazard was revealed in a multi-institutional study led by researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab).

9 Feb 2010

Researchers study link between premature births and cerebral palsy

Cerebral palsy (CP) has increased in infants born prematurely in the United States, according to data presented by researchers from Loyola University Health System (LUHS). These findings were reported at the 30th Annual Meeting of the Society for Maternal-Fetal Medicine in Chicago.

9 Feb 2010

FDA accepts Psyadon Pharmaceuticals' ecopipam IND for treatment of LND

Psyadon Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) to study ecopipam in patients with Lesch-Nyhan Disease (LND). The first center at which the drug will be evaluated is Emory University under the direction of Dr. Hyder A. Jinnah, MD, PhD. The study is designed to evaluate the safety and tolerability of different doses of ecopipam in adults (group 1), adolescents (group 2) and children (group 3) with LND.

9 Feb 2010

New nursing education modules now available from March of Dimes

For nurses seeking up-to-date and cost-effective continuing education on the care of mothers and babies, the March of Dimes is now offering three new publications (modules).

9 Feb 2010

60% of pregnant women never tested for CHD

Three out of five women who have given birth to a child with a congenital heart defect (CHD) -- the number-one birth defect and leading killer of infants and newborns -- were never tested for the defect during pregnancy. This is according to a survey just released by Little Hearts, Inc., a national organization that provides support, education, resources, networking and hope to families affected by congenital heart defects.

9 Feb 2010

Unhealthy behaviors contribute to excessive number of premature deaths in U.S.

The standard American diet, combined with inactivity and other unhealthy lifestyle behaviors, contributes to an excessive number of premature deaths in this country, according to leading preventive cardiology experts speaking at the American College of Cardiology's Fourth Annual Heart of Women's Health Conference in Washington, D.C.

9 Feb 2010

Poor handgrip strength linked to premature mortality, disability and other health complications in older people

Poor or declining handgrip strength in the oldest old is associated with poor survival and may be used as a tool to assess mortality, found an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091278.pdf. The fastest growing segment of the elderly population is the group older than 85 years, classified as the oldest old.

9 Feb 2010

Denosumab exhibits superiority over Zometa in treatment of prostate cancer men with bone metastases

Amgen today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa® (zoledronic acid) in the treatment of bone metastases in 1,901 men with advanced prostate cancer met its primary and secondary endpoints.

9 Feb 2010

Glaucoma medications appear to reduce mortality risk

Glaucoma patients who take medication for the condition appear to have a reduced likelihood of death, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

9 Feb 2010

The anti-trust exemption for health insurers: Meaningful or not?

Kaiser Health News staff writer Jenny Gold writes about legislation to repeal this exemption. "With comprehensive health care legislation foundering in Congress, the House is turning to a narrower piece of legislation that lawmakers hope has widespread, populist appeal: repealing the antitrust exemption for health and medical liability insurers.

9 Feb 2010

Novavax announces new data from trivalent seasonal influenza VLP vaccine study

Novavax, Inc. announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax's trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains.

9 Feb 2010

Finding provides new insight into economic behavior of human beings

Neuroscientists at the California Institute of Technology (Caltech) and their colleagues have tied the human aversion to losing money to a specific structure in the brain-the amygdala.

9 Feb 2010

ebrary introduces new subscription database in Medical Technology

Health care companies that design and manufacture medical devices, equipment, and instruments can now help their technologists, engineers, and other employees conduct research more efficiently and effectively, resulting in greater cost savings and faster development times for new products.

9 Feb 2010

NexMed raises $2.3M through private placement

NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology , announced today that it has raised $2.3 million in a private placement of promissory notes from two accredited U.S. investors. The promissory notes, due on or before August 4, 2010, are repayable at NexMed’s option in either cash or shares of unregistered common stock at prices ranging from $0.36 to $0.40 per share.

9 Feb 2010

Broad coalition supports inclusion of new bill in the Minnesota legislature

A measure to make roads safer and more accessible for all Minnesotans – regardless of age or ability or whether traveling by car, bus, bike or on foot – was introduced into the Minnesota legislature today. The "Complete Streets" bills, SF 2461 and HF 2801, are supported by a broad coalition of health, family, environment, senior, and transportation advocates who attended an afternoon press conference.

9 Feb 2010